The office, people and counterparty names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

L••••••••• L••

Single family office (confirmed)· 5130 Route 212, Willow, NY 12495

Single family office (confirmed), based in 5130 Route 212, Willow, NY 12495, with 2 direct investments on record.

Composed from this office's classification, location and record.

Direct investments
2
Deal announcements, Form D and filings
Decision makers
1 of 1
The office's site, Form ADV Schedule A and filings
Last deployment
2017
The latest dated investment or commitment on record
Contact decision makersFind similar offices
1 export, up to 2 contact reveals
More
Direct investments (2)Mandate
As of · the latest observation of this office; filed figures carry their own filing dates

What matters now

  1. Jul 2011
    latest direct deal

    Latest direct deals: A•••• P••••••••• I••• (biotechnology/pharmaceuticals, $886M check, led, Jul 2011) and T••••• P••••••••• (biotechnology/pharmaceuticals, founding, $780M check, led, Jan 2011). No newer direct deal is on record since 1 Jul 2011.

    What it bought last is the best guide to what it will buy next, and to the check it writes.

    Factannounced deals, press and filingsFor Founders and sponsors raising equityAll direct i••••••••• →
Readings, classification basis and verificationidentity confidence 85% · 16 observations · 3 sourcesShow
Single family office (confirmed)Verified Sep 21, 2026 (3 days ago)1 people · 2 investments · 0 public positions · 9 events

Why this class: TuHURA Biosciences' independent board-of-directors bio page also calls L••••••••• L•• a family office chaired by Dr. M•••••..

Direct investing
30
moderate

Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: external managers, private markets, sponsor-friendly, real estate, co-investment.

Profile completeness 38% (high value, high value shallow; the most valuable missing fact is contacts)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
Overview
show
Classification
Single family office (confirmed)
Description
••• Locked
Headquarters
5130 Route 212, Willow, NY 12495
Office address
unknown
Business phone
unknown
Website
unknown
Year established
unknown
Assets under management
unknown
Capital scale
Reported office AUM: unknown. No public number of any kind.
Classification history
  • Sep 15, 2026Single family office (confirmed) 85%TuHURA Biosciences' independent board-of-directors bio page also calls L••••••••• L•• a family office chaired by Dr. M•••••.Factverifiedir.tuhurabio.com“••• Locked”
  • Sep 14, 2026Single family office (probable) 70%a filing by a third party describes it as a single family office (cited)Fact
  • Sep 14, 2026Candidate 25%no rule matched; held as a candidate pending researchInference
Family and wealth origin
show
Family served
M••••• family
Source of wealth
unknown
Operating company origin
unknown
Team
1 people, 1 with investment decisions, decision makers firstshow
PersonTitleResponsibilityBusiness contactSource
J•••• S• M••••• familyFounder and Managing Member / Chairman and CEOLeadership · investment decisionsnone on record
ir.tuhurabio.com Factsec.gov Fact2 sources agree
Signals and timeline
9show

Most significant first: what kind of change it is, its size, whose change it is, and how recent. 9 events. 13F position changes are under Public stakes and holdings.

  • Apr 30, 2026Office discovered••• LockedDiscoveryFactsec.gov
  • Sep 15, 2026Classification changed••• Lockedc•••••••••Factir.tuhurabio.com
  • Sep 14, 2026Classification changed••• Lockedc•••••••••Factno URL
  • Jan 1, 2017Portfolio exit••• LockedDirect investmentsFactir.tuhurabio.com
  • Jan 1, 2017Portfolio exit••• LockedDirect investmentsFactir.tuhurabio.com
Full timeline · 9 events
  • Oct 1, 2013Portfolio exit••• LockedDirect investmentsFactir.tuhurabio.com
  • Oct 1, 2013Portfolio exit••• LockedDirect investmentsFactir.tuhurabio.com
  • Jul 1, 2011Direct investment••• LockedDirect investmentsFactir.tuhurabio.com
  • Jan 1, 2011Direct investment••• LockedDirect investmentsFactir.tuhurabio.com
Investment mandate
show

••• Locked

Stated (their words, cited)
No cited statement of mandate on the record.
Observed (from the investment record)
States
none Fact
Control
unknown (2) Fact
Sectors
biotechnology/pharmaceuticals (2) Fact
Subsectors
none Fact
Co investors
none Fact
Asset classes
private equity (2) Fact
Direct vs fund
Fund: 0 · Direct: 2 · Real estate: 0 Fact
Sponsors backed
none Fact
Investment count
2 Fact
Investment kinds
operating company (chairman/CEO) (1), spin-out biotech (founder) (1) Fact
First and last deal
Last: 2011-07-01 · First: 2011-01-01 Fact
Lead vs participant
lead (2) Fact
Disclosed check sizes
Max: $886M · Min: $780M · Count: 2 Fact
••• Locked
Inferred (regulatory shape and team)
Nothing to infer from.
Invests directly
unknown
Allocates to managers
unknown
Asset classes
unknown
Sectors
unknown
Geography
unknown
Check size
unknown
Direct investments
2 dealsshow
DateCompanyKindSectorRoleAmountWithSource
Jul 1, 2011
exit Oct 1, 2013
A•••• P••••••••• I•••Operating company (chairman/CEO)biotechnology/pharmaceuticalslead$886Mnone named
ir.tuhurabio.com Fact
“••• Locked”
Jan 1, 2011
exit Jan 1, 2017
T••••• P•••••••••Spin-out biotech (founder)biotechnology/pharmaceuticalslead$780Mnone named
ir.tuhurabio.com Fact
“••• Locked”
Fund and manager relationships
show
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdings
show
Form 13F holdings
No 13F filing on the record for this office.
Real estate
show
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors
show
No co-investor on the record.
Independent sponsor relationships
show
No cited relationship to an independent sponsor.
Related entities
show
Sources and evidence
16show

Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 16 shown.

Score components
Freshness
+100 d••• s•••• t•• n••••• s••••••••• f••• o• a•••••• v••••••••• (1 days)
Contactability
+40 n•••• d••••••••• (••• Locked)
Data confidence
+10 d•••••••••
+10 p•••••
+15 i•••••••••
+15 i••••••••• s•••••• (3 sources)
Active deployment
no components; scored 0
Exists confidence
+30 i••••••••• s•••••• (3 sources)
+30 a•••••••••
Research priority
+15 s••••• f••••• o• f••••• i••••••••• c••••••
+6 d••••• i••••••••• o• r•••••
+2 n• w•••••• k•••• •••••••• w•••• f••• o•••
+0 r••• (507)
Mandate confidence
+20 m•••••• s•••••••• b• o••••••• i•••••••••
Identity confidence
+85 c••••••••• (••• Locked)
Real estate propensity
no components; scored 0
Co investment propensity
no components; scored 0
Family identity confidence
+40 f••••• n•••• (M••••• family)
Private markets propensity
no components; scored 0
Current activity confidence
+25 a• s••••••••• f••• w••••• 1• m••••• (145 days)
External manager propensity
no components; scored 0
Direct investment propensity
+30 o••••••• d••••• i••••••••• (2 on the record)
Independent sponsor propensity
no components; scored 0
View all 16 observations
FactValueEffectiveSourceClass
Board participation••• Locked
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) ir.tuhurabio.comFact
Board participation••• Locked
“••• Locked”
Aug 1, 2015DFX analyst research (General-assisted, every claim URL-cited) respirerx.comFact
Description••• Locked
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) ir.tuhurabio.comFact
Description••• Locked
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) ir.tuhurabio.comFact
Description••• Locked
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) ir.tuhurabio.comFact
Edgar fts discoveryfamily officeApr 30, 2026SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.govFact
External consultant••• Locked
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) ir.tuhurabio.comFact
Family servedM••••• family
“••• Locked”
n/aDFX analyst research (General-assisted, every claim URL-cited) sec.govFact
Formation year2018
“••• Locked”
May 7, 2018DFX analyst research (General-assisted, every claim URL-cited) opengovus.comFact
Headquarters5130 Route 212, Willow, NY 12495
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) opengovus.comFact
Legal entity••• Locked
“••• Locked”
Sep 21, 2026DFX analyst research (General-assisted, every claim URL-cited) opengovus.comFact
Legal entity••• Locked
“••• Locked”
Aug 20, 2019DFX analyst research (General-assisted, every claim URL-cited) opengovny.comFact
Office type (stated)Single family office
“••• Locked”
Sep 15, 2026DFX analyst research (General-assisted, every claim URL-cited) ir.tuhurabio.comFact
Office type (stated)Single family officeApr 30, 2026SEC EDGAR full-text search (a filing sentence that says what an entity is, quoted with its URL) sec.govFact
Website searchNot foundSep 16, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference
Website searchNot foundSep 14, 2026DFX model output (c••••••••• rules, scores, mandates, matches) no URLInference

Not yet on record: capital scale.